Web Analytics

3 Latest Announced Rounds

  • $23,000,000
    Series B

    1 Investors

    Medical Device
    May 30th, 2025
  • $4,000,000
    Seed

    2 Investors

    Information Technology & Services
    May 30th, 2025
  • $10,000,000
    Series A

    3 Investors

    Financial Services
    May 30th, 2025
$545.74M Raised in 54 Funding Rounds in the past 7 Days - View All

Funding Round Profile

IMU Biosciences

start up
United Kingdom - London
  • 25/01/2024
  • Series A
  • $14,639,787

Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.


Related People

Adam LaingCo Founder

Adam Laing United Kingdom - London, England

N/A